Affimed N.V. [NASDAQ: AFMD] slipped around -0.5 points on Tuesday, while shares priced at $8.37 at the close of the session, down -5.64%. The company report on May 26, 2021 that Affimed to Present at the Jefferies Virtual Healthcare Conference 2021.
Heidelberg, Germany, May 26, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that its Chief Executive Officer, Dr. Adi Hoess, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:30 a.m. Eastern Time.
A live webcast of the presentation will be accessible on Affimed’s website at https://www.affimed.com/investors/webcasts_cp/. A replay of the call will be archived on Affimed’s website for 30 days after the call.
Affimed N.V. stock is now 43.81% up from its year-to-date (YTD) trading value. AFMD Stock saw the intraday high of $9.03 and lowest of $8.21 per share. The company’s 52-week high price is 11.74, which means current price is +75.10% above from all time high which was touched on 04/26/21.
Compared to the average trading volume of 3.50M shares, AFMD reached a trading volume of 2168288 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Affimed N.V. [AFMD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AFMD shares is $15.49 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AFMD stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Credit Suisse have made an estimate for Affimed N.V. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 31, 2021. The new note on the price target was released on March 28, 2019, representing the official price target for Affimed N.V. stock.
The Average True Range (ATR) for Affimed N.V. is set at 0.56, with the Price to Sales ratio for AFMD stock in the period of the last 12 months amounting to 29.36. The Price to Book ratio for the last quarter was 8.81, with the Price to Cash per share for the same quarter was set at 1.47.
How has AFMD stock performed recently?
Affimed N.V. [AFMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.41. With this latest performance, AFMD shares dropped by -21.70% in over the last four-week period, additionally plugging by 58.22% over the last 6 months – not to mention a rise of 157.54% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AFMD stock in for the last two-week period is set at 38.15, with the RSI for the last a single of trading hit 31.53, and the three-weeks RSI is set at 43.17 for Affimed N.V. [AFMD]. The present Moving Average for the last 50 days of trading for this stock 9.28, while it was recorded at 8.76 for the last single week of trading, and 6.07 for the last 200 days.
Affimed N.V. [AFMD]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Affimed N.V. [AFMD] shares currently have an operating margin of -124.63. Affimed N.V.’s Net Margin is presently recorded at -145.86.
Return on Total Capital for AFMD is now -58.97, given the latest momentum, and Return on Invested Capital for the company is -70.92. Return on Equity for this stock declined to -71.73, with Return on Assets sitting at -27.65. When it comes to the capital structure of this company, Affimed N.V. [AFMD] has a Total Debt to Total Equity ratio set at 1.80. Additionally, AFMD Total Debt to Total Capital is recorded at 1.77, with Total Debt to Total Assets ending up at 0.74. Long-Term Debt to Equity for the company is recorded at 0.99, with the Long-Term Debt to Total Capital now at 0.97.
Reflecting on the efficiency of the workforce at the company, Affimed N.V. [AFMD] managed to generate an average of -$289,302 per employee. Receivables Turnover for the company is 13.91 with a Total Asset Turnover recorded at a value of 0.19.Affimed N.V.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.20 and a Current Ratio set at 2.20.
Earnings analysis for Affimed N.V. [AFMD]
With the latest financial reports released by the company, Affimed N.V. posted -0.13/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 13.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AFMD.
Insider trade positions for Affimed N.V. [AFMD]
There are presently around $655 million, or 67.60% of AFMD stock, in the hands of institutional investors. The top three institutional holders of AFMD stocks are: BLACKROCK INC. with ownership of 7,028,783, which is approximately 31.587% of the company’s market cap and around 2.79% of the total institutional ownership; CONSONANCE CAPITAL MANAGEMENT LP, holding 6,008,974 shares of the stock with an approximate value of $50.3 million in AFMD stocks shares; and NEA MANAGEMENT COMPANY, LLC, currently with $45.24 million in AFMD stock with ownership of nearly -11.772% of the company’s market capitalization.
Positions in Affimed N.V. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 81 institutional holders increased their position in Affimed N.V. [NASDAQ:AFMD] by around 26,395,289 shares. Additionally, 45 investors decreased positions by around 7,103,888 shares, while 15 investors held positions by with 44,759,455 shares. The mentioned changes placed institutional holdings at 78,258,632 shares, according to the latest SEC report filing. AFMD stock had 20 new institutional investments in for a total of 12,494,449 shares, while 13 institutional investors sold positions of 933,042 shares during the same period.